Need Help? Call 1­-866-­796-­7386
« back to stock screener

  INCY stock: Incyte Corporation

Current Rating
Sell

Previous Rating

Hold/Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$96.41
Market Cap
20.89B
Sector
Health Care
Div. Growth
-
P/E
-
P/B
11.52
P/S
14.28
Dividend %
-
P/CF
39.2
P/FCF
-
Op. Cash Flow
90.7K
FCF
0.0
Op. Margin
-4.90%
Net Margin
-10.90%
ROE
-14.80%
ROI
13.20%
ROA
-8.50%
EPS Growth
-199.20%
Current Ratio
3.6
Debt/Equity
155.30%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Aviragen Therapeutics Inc (AVIR) $0.59 - - 24.7M Strong Buy
AdvanSource Biomaterials Corpo (ASNB) $0.06 - - 1.2M Strong Buy
Nature's Sunshine Prod. (NATR) $12.10 - 3.20% 242.9M Strong Buy
Apollo Medical Holdings Inc (AMEH) $18.16 - - 58.5M Strong Buy
ImmunoGen, Inc. (IMGN) $6.43 - - 982.8M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More